Pain Management Therapeutics Market Size, Share, By Drug Class, Indication, Route of Administration, Distribution Channel, and By Region - Trends, Analysis and Forecast till 2035

Report Code: PMI110119 | Publish Date: March 2024 | No. of Pages: 189

Global Pain Management Therapeutics Market Companies

  • Teva Pharmaceutical Industries Ltd
  • Pfizer
  • Abbott
  • Mallinckrodt Pharmaceuticals
  • Endo, Inc.
  • GSK Group
  • AstraZeneca
  • Merck & Co., Inc.
  • Novartis AG
  • Lilly
  • MYLAN N.V.
  • Sanofi
  • DAIICHI SANKYO COMPANY, LIMITED
  • Zoetis Services LLC
  • Averitas Pharma

Recent News:

  • Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) for its lead investigational product ATX101 for treatment of postsurgical pain following TKA procedures in adults in December 2024. This BTD was granted based on clinical data from a Phase 2 exploratory dose-ranging trial for the treatment of Post-Surgical Pain following Total Knee Arthroplasty (TKA), or replacement.
  • CureLab Oncology, a clinical-stage biotech company dedicated to pioneering innovative therapies, announced a patent application for an innovative chronic pain treatment centered on its p62/SQSTM1 DNA plasmid in November 2024. This development, which leverages CureLab's chronic inflammation therapeutic, Elenagen, signifies a potential paradigm shift in addressing chronic pain, a pervasive health challenge that affects millions globally.